文献速递临床试验与 GCP真实世界研究与卫生经济

PART试验统计分析计划:全膝关节置换髌骨置换策略的临床与成本效果随机对照试验

The clinical and cost-effectiveness of elective primary total knee replacement with PAtellar Resurfacing compared to selective patellar resurfacing: a pragmatic multicentre randomised controlled Trial with blinding (PART) - statistical analysis plan.
PubMed 文献 · Trials · 2026-05-20

PART试验是一项多中心、随机、盲法、实用性平行两组优效性RCT,计划招募990例初次全膝关节置换患者,比较选择性髌骨置换与常规髌骨置换的临床与成本效果。主要结局为术后12个月牛津膝关节评分。本文在数据收集完成前前瞻性发布统计分析计划,详述主要与次要结局的分析方法及缺失数据、多重检验等处理策略。

要点

  • PART试验比较选择性髌骨置换与常规髌骨置换的临床与成本效果。
  • 计划招募990例初次全膝关节置换患者,主要结局为12个月OKS。
  • 统计分析计划前瞻性发布以降低报告偏倚和数据驱动分析风险。

核心结论

  • 本文前瞻性描述PART试验的统计分析计划,旨在降低报告偏倚和数据驱动分析的风险。

研究设计与样本

  • PART为多中心、随机、盲法、实用性平行两组优效性RCT,计划招募990例初次全膝关节置换患者。

关键数值与推荐

  • 主要结局为全膝关节置换术后12个月牛津膝关节评分(OKS)。
  • 分析计划遵循ICH-GCP、临床试验统计分析计划内容指南及CONSORT声明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The PAtellar Resurfacing compared to selective patellar resurfacing Trial (PART) is a randomised controlled trial (RCT) to evaluate the clinical and cost-effectiveness of selective patellar resurfacing (intraoperative decision by surgeon) compared to always patellar resurfacing in patients undergoing elective primary total knee replacement (TKR). This paper presents the PART statistical analysis plan, detailing the trial analysis and presentation plan. The proposed analysis follows recommendations from the International Council for Harmonisation guideline on Good Clinical Practice and "Guidelines for the Content of Statistical Analysis Plans in Clinical trials" and are in line with the Consolidated Standards of Reporting Trials. METHODS/DESIGN: PART is a multi-centre, randomised, blinded, pragmatic parallel two-group superiority RCT aiming to recruit 990 patients undergoing primary TKR. The primary outcome is the Oxford Knee Score (OKS) 12 months after TKR surgery. The planned statistical analyses of the trial primary and secondary outcomes are described in detail, including approaches to deal with the following: missing data, multiple testing, violation of model assumptions, withdrawals from the trial, non-adherence with the treatment and other protocol deviations. DISCUSSION: This manuscript prospectively describes, prior to the completion of data collection and database lock, the analyses to be undertaken for the PART trial to reduce the risk of reporting bias and data-driven analyses. TRIAL REGISTRATION: The trial was registered as ISRCTN33276681 on 27 Feb 2023, before recruitment began.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Evans RN, Judge A, Matharu GS, et al. The clinical and cost-effectiveness of elective primary total knee replacement with PAtellar Resurfacing compared to selective patellar resurfacing: a pragmatic multicentre randomised controlled Trial with blinding (PART) - statistical analysis plan. Trials. 2026. PMID: 42163296. doi:10.1186/s13063-026-09807-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。